RNA Binding Motif Protein 3 Promotes Cell Metastasis and Epithelial–Mesenchymal Transition Through STAT3 Signaling Pathway in Hepatocellular Carcinoma
Lu Zhang,Yi Zhang,Dongliang Shen,Ying Chen,Jianguo Feng,Xing Wang,Lunkun Ma,Yi Liao,Liling Tang
DOI: https://doi.org/10.2147/JHC.S351886
2022-05-09
Journal of Hepatocellular Carcinoma
Abstract:Lu Zhang, 1, &ast Yi Zhang, 1, &ast Dongliang Shen, 1 Ying Chen, 1 Jianguo Feng, 2 Xing Wang, 1 Lunkun Ma, 1 Yi Liao, 3, 4 Liling Tang 1 1 Key Laboratory of Biorheological Science and Technology, Ministry of Education, College of Bioengineering, Chongqing University, Chongqing, 400044, People's Republic of China; 2 Southwest Medical University, Department Anesthesiology, Affiliated Hospital, Luzhou, 646000, People's Republic of China; 3 The Central Laboratory, Shenzhen Second People's Hospital/First Affiliated Hospital of Shenzhen University Health Science Center, Shenzhen, Guangdong, 518035, People's Republic of China; 4 Department of Thoracic Surgery, Southwest Hospital, Army Medical University, Chongqing, 400038, People's Republic of China &astThese authors contributed equally to this work Correspondence: Liling Tang; Yi Liao, Tel +86 139 9605 1730 ; +86 139 9656 6993, Fax +86-23-65111901 ; +86-23-68763333, Email ; Purpose: RNA binding motif protein 3 (RBM3) has been reported to be dysregulated in various cancers and associated with tumor aggressiveness. Epithelial–mesenchymal transition (EMT) is an important biological process by which tumor cells acquire metastatic abilities. This study aimed to explore the regulatory and molecular mechanisms of RBM3 in EMT process. Methods: Western blotting, IHC, and qRT-PCR were performed to evaluate the expression of target genes. Transwell assay was used to investigate the migration and invasion. RNA immunoprecipitation and luciferase reporter assay were performed to explore the correlation of RBM3 with STAT3 or microRNA-383. Animal HCC models were used to explore the role of RBM3 in metastasis in vivo. Results: RBM3 was highly expressed in HCC tissues compared to healthy tissues, and its level was negatively correlated with the prognosis of HCC patients. RBM3 overexpression accelerated migration and invasion, promoted EMT process, and activated STAT3 signaling. EMT induced by RBM3 was not only attenuated by inhibiting pSTAT3 via S3I-201 but also abolished by suppressing STAT3 expression via siRNAs. Mechanistically, RBM3 increased STAT3 expression by stabilizing STAT3 mRNA via binding to its mRNA. As an upstream target of RBM3, microRNA-383 inhibited RBM3 expression by binding to its 3ʹUTR and resulted in the inhibition of the EMT process. Inhibition of RBM3 in HCC animal models prolonged survival and ameliorated malignant phenotypes in mice. Conclusion: Our findings support that RBM3 promotes HCC metastasis by activating STAT3 signaling. Keywords: RBM3, metastasis, EMT, STAT3, microRNA-383 Hepatocellular carcinoma (HCC), one of the four most common types of cancer, always holds a high morbidity and mortality. 1 Although increasing number of studies have explored the relevant molecular mechanisms, the prognosis of HCC remains unsatisfactory, mainly due to metastasis and postoperative recurrence. 2–4 Nowadays, the cancer therapy is still a very intractable problem because of its highly metastatic nature. Metastasis of tumor cells is life-threatening, and it could lead to the spread of tumor cells from situ tissues to other healthy tissues. Therefore, it is of great clinical value to explore the underlying mechanisms of tumor metastasis. Epithelial–mesenchymal transition (EMT) is an important biological process that cannot be ignored in the acquisition of aggressive capabilities by tumor cells. Epithelial cells acquire motility through EMT, and the migration speed of mesenchymal cells could also be improved by adopting amoeboid features. 5 CD138, a positive marker of cell migration, was increased in human mammary epithelial cells undergoing EMT induced by TGFβ1 or 4-hydroxytamoxifen. 6 Furthermore, the mesenchymal state allows cells to migrate to distant organs and maintain stemness. 7 EMT is characterized by losing cell morphology, polarity, adhesion and down-regulation of E-cadherin, as well as up-regulation of N-cadherin and Vimentin. 8 Primary tumors could acquire migratory and invasive abilities through EMT and form metastases. 9,10 A large number of studies have shown that EMT is associated with metastasis of various cancers, such as breast cancer, 11 nasopharyngeal carcinoma, 12 head and neck squamous carcinoma, 13 colorectal cancer 14 and so on. EMT has been shown to play a vital role in the development and progression of HCC, providing the possibility for HCC to adapt to the tumor microenvironment and acquire the ability to migrate and invade. 15–17 The importance of EMT in HC -Abstract Truncated-
oncology